Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Ablation”

379 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 379 results

Testing effectiveness (Phase 2)Looking for participantsNCT04150744
What this trial is testing

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Who this might be right for
Tumor ImmunityImmunosuppressionRadiofrequency Ablation
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Large-scale testing (Phase 3)Study completedNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Testing effectiveness (Phase 2)Study completedNCT00030563
What this trial is testing

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Washington
Post-approval studies (Phase 4)UnknownNCT01570075
What this trial is testing

Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824856
What this trial is testing

Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNeoplasm MetastasisLung Metastases+3 more
Sun Yat-sen University 138
Not applicableStudy completedNCT07559851
What this trial is testing

Ablation With Systemic Therapy vs Liver Resection With Systemic Therapy for Colorectal Liver Metastasis

Who this might be right for
Colorectal Liver Metastasis (CRLM)
The First Hospital of Jilin University 151
Not applicableStudy completedNCT05370001
What this trial is testing

Endotracheal Tube Size Effect on the Carbon Dioxide Washout During Jet Ventilation

Who this might be right for
Liver Tumor
Region Stockholm 26
Testing effectiveness (Phase 2)Study completedNCT00004136
What this trial is testing

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT05162898
What this trial is testing

Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.

Who this might be right for
Recurrent Hepatocellular Cancer
Henan Cancer Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06766643
What this trial is testing

Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
Tianjin Medical University Cancer Institute and Hospital 130
Not applicableUnknownNCT02806076
What this trial is testing

RFA for Small HCC With No-touch Technique and Dual Cooled-Wet Electrode

Who this might be right for
Carcinoma, Hepatocellular
Seoul National University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01853618
What this trial is testing

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Who this might be right for
Heptocellular CancerBiliary Tract NeoplasmsLiver Cancer+2 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Study completedNCT00063960
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 94
Early research (Phase 1)Study completedNCT02210182
What this trial is testing

A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Oncozyme Pharma Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00004142
What this trial is testing

Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
M.D. Anderson Cancer Center 40
Not applicableUnknownNCT00730860
What this trial is testing

Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE

Who this might be right for
Cancer of Liver
Southwest Hospital, China 140
Not applicableStudy completedNCT01720706
What this trial is testing

Thermal Ablation in Larger Liver and Kidney Tumours

Who this might be right for
Liver and Kidney Tumours
University Health Network, Toronto 12
Testing effectiveness (Phase 2)Ended earlyNCT00019604
What this trial is testing

Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

Who this might be right for
Liver CancerMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 44
Large-scale testing (Phase 3)UnknownNCT00728078
What this trial is testing

Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 200
Next Page